PDCD1 and neoplasm: The tumor microenvironment cell fresh flow analysis was available for seven patients: three patients exposed to anti-PD-1 (Pts #1, #2, #3) and four control patients not exposed to anti-PD-1 (pts #5, #6, #7 and #8).